Your browser doesn't support javascript.
loading
Using a System Pharmacology Method to Search for the Potential Targets and Pathways of Yinqiaosan against COVID-19.
Cao, Li-Hua; Jia, Xing-Yuan; He, Hong-Juan; Wang, Zhen-Zhen; Zhao, Yi-Ying; Yang, Xue; Li, Xiu-Min; Miao, Ming-San.
Afiliação
  • Cao LH; Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China.
  • Jia XY; Department of Pharmacy, Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou 450046, Henan Province, China.
  • He HJ; Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China.
  • Wang ZZ; Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China.
  • Zhao YY; School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China.
  • Yang X; School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China.
  • Li XM; Microbiology and Immunology Department, New York Medical College, Valhalla, NY 10595, USA.
  • Miao MS; Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China.
J Healthc Eng ; 2022: 9248674, 2022.
Article em En | MEDLINE | ID: mdl-35340244
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Healthc Eng Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Healthc Eng Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China